Drug intelligence / Profile preview

Modulen IBD

Development stage: Phase 4
Lead developer: Nestlé Health Science
Administration: Oral, Enteral

Overview

**Modulen IBD** is a proprietary, nutritionally complete polymeric enteral nutrition formula developed by Nestlé Health Science for the dietary management of active Crohn's disease, particularly as exclusive enteral nutrition in pediatric patients. It is a casein-based, lactose-free formula enriched with transforming growth factor beta 2 and supplied as an oral or tube-feeding nutritional product. Its therapeutic rationale combines nutritional repletion and exclusion of usual dietary exposures with potential anti-inflammatory and mucosal-repair effects attributed to transforming growth factor beta 2. Clinical studies have evaluated Modulen IBD for induction of remission, mucosal healing, nutritional recovery, and maintenance support in Crohn's disease; it has also been studied as adjunctive nutritional support in pediatric ulcerative colitis. It is a medical nutrition product rather than an INN-designated pharmaceutical active ingredient.

Brand names: Modulen IBD
Other names: ModulenModulen IBD oral polymeric diet

Targets

TGFBR1

Beyond the preview

Go deeper on Modulen IBD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modulen IBD.

Explore the full profile